Lumen Biomedical Inc
Wearable contact lens for continuous intraocular pressure monitoring and autonomous glaucoma treatment delivery
- Sector
- Medtech
- Headquarters
- MAPLE GROVE, MN
- Latest Form D
- $675K, Oct 2009
- Total capital
- $675K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $675K
- 1 Form D · last Oct 2009
- 205 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 10 pending · first 2017
- Rank in peer group#337 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$675K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#337 · top 30%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Matthew F. OgleExecutive Officer, DirectorNamed in SEC Form D filings
- Nancy A. NessExecutive OfficerNamed in SEC Form D filings
- Randy F. LaBountyExecutive OfficerNamed in SEC Form D filings
- Steven J. HealyExecutive Officer, DirectorNamed in SEC Form D filings
- Thomas A. LetscherExecutive OfficerNamed in SEC Form D filings
- Todd A. BergDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 14- PendingEmbolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresUSPTOApplication 17104476
- GrantedEmbolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresUSPTOUS 10,881,496
- GrantedAortic Arch Filtration Catheter For Carotid Artery Protection And Methods Of UseUSPTOUS 10,682,217
Show all 14 patent records
- Embolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresSep 2, 2021 · Application 17104476Pending
- Embolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresJan 5, 2021 · US 10,881,496Granted
- Aortic Arch Filtration Catheter For Carotid Artery Protection And Methods Of UseJun 16, 2020 · US 10,682,217Granted
- Embolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresApr 17, 2018 · US 9,943,396Granted
- Aortic Arch Filtration System For Carotid Artery ProtectionOct 24, 2017 · US 9,795,470Granted
- Extendable Device On An Aspiration CatheterApplication PCTUS2005042509Pending
- Emboli Filter Export SystemApplication PCTUS2005018334Pending
- Steerable Device Having A Corewire Within A Tube And Combination With A Functional Medical ComponentApplication PCTUS2005007511Pending
- Medical Articles Incorporating Surface Capillary FiberApplication PCTUS2004023194Pending
- Fiber Based Embolism Protection DeviceApplication PCTUS2004022839Pending
- Aortic Arch Filtration System For Carotid Artery ProtectionApplication PCTUS2013021734Pending
- Embolectomy Devices And Methods For Treatment Of Acute Ischemic Stroke ConditionApplication PCTUS2011032098Pending
- Embolic Protection During Percutaneous Heart Valve Replacement And Similar ProceduresApplication PCTUS2009003705Pending
- Thrombectomy Catheters And Other Aspiration CathetersApplication PCTUS2006032189Pending
Related companies, and why
- RAVGEN, INC.Similar federal contract value in Medtech · null in contracts
- Cyto Wave Technologies Inc.Similar federal contract value in Medtech · null in contracts
- Eva Medtec, IncSimilar federal contract value in Medtech · null in contracts
- Kardia Health Systems Inc.Similar federal contract value in Medtech · null in contracts
- Xsphera Biosciences IncorporatedSimilar federal contract value in Medtech · null in contracts
- CHELAK MEDICAL SOLUTION INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .